How We WorkOrder NowSupport Privacy

Hot Penny Stocks Watch List – FOYJ, ITNS, GNBT, GVIT

on 01/02/2013

Houston, TX – February 1st, 2013 — (Net PR News) – delivers quality trading ideas for the elite investor that has the financial wherewithal and market nimbleness to profit on small moves in a stock’s price. Become a member and you will be provided with real-time alerts intended to provide you with the opportunity to make profitable trades. To receive our FREE, comprehensive newsletter, visit

Stocks that are being watched this morning are: FOYJ, ITNS, GNBT, GVIT

FOY JOHNSTON INC (PINK:FOYJ) shares closing price for the day was$0.0014 with the total traded volume of 152.38 million shares, more than average volume of 3.53 million.

Company’s year to date performance remained optimistic with the rise of 180%. If we look at the last 6 months of trade, that is in the bullish zone with an increase of 1300%. The company’s total market capitalization is $172.38 million.

Get A Free Report And Detailed Analysis On FOYJ CLICK HERE To Read

FOY JOHNSTON INC (PINK:FOYJ has announced it has reached an agreement to acquire a concession in the Congo Craton region of Cameroon.

ITonisInc (PINK:ITNS) started its trading session with the price $0.03 and closed at $0.0089 by decreasing -63.22%. Day trading range of ITNS was $0.01 -$0.03.

Itonis, Inc. (ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy and founding member of Itonis Pharmaceuticals, reported that they have selected a manufacturer for their homeopathic nasal spray for nausea relief.

Previous 5 days graph demonstrated a negative move of -31.54%. ITNS’s quarterly performance remained in the red with the percentage of -42.21, while its year to date performance showed that the stock plunged overall -11.88%.

How Should Investors React To ITNS Now? Find Out In This TREND ANALYSIS REPORT

ITNS’s stocks traded with total volume of 63.54 million shares, while the average trading capacity remained 1.48 million shares. The beta of ITNS stands at 1.59.

Generex Biotechnology Corporation (OTC:GNBT), during the previous trading session, showed a negative movement of -29.47%. Currently, the company has a market capitalization of $16.74 million. Stock’s closing price was $0.0450, while it started its day-trade at $0.06. Its 52-week price range was $0.02 – $0.19.

How Should Investors Trade GNBT Now? Don’t Trade GNBT Until You Read This TREND ANALYSIS REPORT

Year to date performance of the stock remained positive with the rise of 80%. GNBT traded with volume of 49.69 million shares, while its average trading volume remained 5.69 million shares.

GEO VISION INTERNATO (PINK:GVIT) stock’s trade opened at $0.01 and, as day trade closed, its price was $0.0125 after scoring 4.17%. The market capitalization of GVIT was 244,400 shares. Total traded volume of the stock was 16.55 million shares, while the company’s average volume remained 584,652 shares.

GVIT’s 52 week range was $0.01- $0.05. During the last 5 trades the stock plummeted -30.56%. During its last 3 months it slipped -16.67%. Its year to date performance remained progressive 25%.

GEO VISION INTERNATO, a nutraceutical and Skinceutical Company targeting Baby Boomers, reported that it has become a verified merchant on

Is GVIT A Solid Investment At These Levels? Find Out Exactly Where GVIT Is Headed With This TREND ANALYSIS REPORT


Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails. 

Source: anotherwinningtrade Posted Fri, February 01, 2013 14:43 - Permalink